Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease.
about
Radionuclide Therapy of Bone Metastases.Strengths and Weaknesses of a Planar Whole-Body Method of (153)Sm Dosimetry for Patients with Metastatic Osteosarcoma and Comparison with Three-Dimensional Dosimetry.A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.Phase I/II trials of 186Re-HEDP in metastatic castration-resistant prostate cancer: post-hoc analysis of the impact of administered activity and dosimetry on survival.
P2860
Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Skeletal uptake and soft-tissu ...... with metastatic bone disease.
@ast
Skeletal uptake and soft-tissu ...... with metastatic bone disease.
@en
type
label
Skeletal uptake and soft-tissu ...... with metastatic bone disease.
@ast
Skeletal uptake and soft-tissu ...... with metastatic bone disease.
@en
prefLabel
Skeletal uptake and soft-tissu ...... with metastatic bone disease.
@ast
Skeletal uptake and soft-tissu ...... with metastatic bone disease.
@en
P2093
P1476
Skeletal uptake and soft-tissu ...... s with metastatic bone disease
@en
P2093
P304
P407
P577
2001-02-01T00:00:00Z